NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit
Portfolio Pulse from
Rosen Law Firm is inviting investors who purchased Intellia Therapeutics securities between July 30, 2024, and January 8, 2025, to join a securities fraud lawsuit. The deadline for lead plaintiff applications is April 14, 2025.
March 20, 2025 | 12:30 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Intellia Therapeutics is facing a securities fraud lawsuit for the period between July 30, 2024, and January 8, 2025. Investors can join the lawsuit with a lead plaintiff deadline of April 14, 2025.
The announcement of a securities fraud lawsuit against Intellia Therapeutics is likely to negatively impact its stock price in the short term as it raises concerns about the company's legal and financial standing. The lawsuit pertains to a specific period, which may affect investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100